1-2 of 2
Lingyun Ji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD22 low /Bcl-2 high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

Clinical Trials & Observations
Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, Courtney Tamaki, Joshua Fandel, Lingyun Ji, Brent L. Wood, Nirali N. Shah, Constance M. Yuan, Maureen M. O’Brien, Mignon L. Loh, Ernesto Diaz-Flores
Journal: Blood Advances
Blood Adv (2023) 7 (2): 251–255.
https://doi.org/10.1182/bloodadvances.2021006810
Published: 2023
Includes: Supplemental data
Journal Articles

Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children’s Oncology Group

Clinical Trials & Observations
Yousif Matloub, Karen R. Rabin, Lingyun Ji, Meenakshi Devidas, Johann Hitzler, Xinxin Xu, Bruce C. Bostrom, Linda C. Stork, Naomi Winick, Julie M. Gastier-Foster, Nyla A. Heerema, Eileen Stonerock, William L. Carroll, Stephen P. Hunger, Paul S. Gaynon
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1647–1656.
https://doi.org/10.1182/bloodadvances.2019032094
Published: 2019
Includes: Supplemental data